Sebastian Krych

Mr. Sebastian Krych

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PKPaweł Kowalczyk
Paweł Kowalczyk
SKSebastian Krych
Sebastian Krych
KKKarol Kramkowski
Karol Kramkowski
AJAgata Jęczmyk
Agata Jęczmyk
THTomasz Hrapkowicz
Tomasz Hrapkowicz
The literature analysis conducted in this review discusses the latest achievements in the identification of cardiovascular damage induced by oxidative stress with secondary platelet mitochondrial dysfunction. Damage to the platelets of mitochondria as a result of their interactions with reactive oxygen species (ROS) and reactive nitrogen species (RNS) can lead to their numerous ischemic events associated with hypoxia or hyperoxia processes in the cell. Disturbances in redox reactions in the platelet mitochondrial membrane lead to the direct oxidation of cellular macromolecules, including nucleic acids (DNA base oxidation), membrane lipids (lipid peroxidation process) and cellular proteins (formation of reducing groups in repair proteins and amino acid peroxides). Oxidative changes in biomolecules inducing tissue damage leads to inflammation, initiating pathogenic processes associated with faster cell aging or their apoptosis. The consequence of damage to platelet mitochondria and their excessive activation is the induction of cardiovascular and neurodegenerative diseases (Parkinson’s and Alzheimer’s), as well as carbohydrate metabolism disorders (diabetes). The oxidation of mitochondrial DNA can lead to modifications in its bases, inducing the formation of exocyclic adducts of the ethano and propano type. As a consequence, it disrupts DNA repair processes and conduces to premature neoplastic transformation in critical genes such as the p53 suppressor gene, which leads to the development of various types of tumors. The topic of new innovative methods and techniques for the analysis of oxidative stress in platelet mitochondria based on methods such as a nicking assay, oxygen consumption assay, Total Thrombus formation Analysis System (T-Tas), and continuous-flow left ventricular assist devices (CF-LVADs) was also discussed. They were put together into one scientific and research platform. This will enable the facilitation of faster diagnostics and the identification of platelet mitochondrial damage by clinicians and scientists in order to implement adequate therapeutic procedures and minimize the risk of the induction of cardiovascular diseases, including ischemic events correlated with them. A quantitative analysis of the processes of thrombus formation in cardiovascular diseases will provide an opportunity to select specific anticoagulant and thrombolytic drugs under conditions of preserved hemostasis.

Verified
Journal Article
Open access
PDF file
SKSebastian Krych
Sebastian Krych
AJAgata Jęczmyk
Agata Jęczmyk
MJMichał Jurkiewicz
Michał Jurkiewicz
MŻMartyna Maria Żurek
Martyna Maria Żurek
MJMałgorzata Jekiełek
Małgorzata Jekiełek
THTomasz Hrapkowicz
Tomasz Hrapkowicz
Myocarditis (MC) is defined as an immunological inflammatory reaction with various etiologies, clinical presentations and prognoses within the myocardium. Currently, parvovirus B19 (PVB19) has become the main factor leading to this disease, replacing the previously dominant viruses A and B. In the case of chronic heart failure with subsequent dilated cardiomyopathy, approximately 67% have a viral etiology, and most of them are the result of PVB19 infection. However, the analysis showed a correlation between PVB19 infection and the risk of developing inflammatory dilated cardiomyopathy (DCMi). PVB19 is detected in 23% of patients with DCMi. Chronic infection may also contribute to progressive left ventricular failure in patients with a history of MC. The above effect suggests the active replication of PVB19 only in heart biopsies with inflammation due to MC or DCMi. Moreover, the supply of IFN-β to suppress the active transcription of PVB19 accompanied by DCMi over a period of 6 months results in the normalization of NT-proBNP and an improvement in LVEF along with NYHA performance. The small number of reports on this topic and inaccuracies resulting from constantly conducted research and ongoing changes make it impossible to clearly answer the question of whether PVB19 is a factor inducing de novo MC and DCM or only accompanies the above conditions. However, large clinical cohort studies lead to the perception of PVB19 as a viral etiological agent capable of causing de novo MC together with DCMi.

20 December 2022 in Polish Journal of Surgery
Verified
Journal Article
Closed access
TBTomasz Banasiewicz
Tomasz Banasiewicz
WMWaldemar Machała
Waldemar Machała
MWMaciej Borejsza Wysocki
Maciej Borejsza Wysocki
MLMaciej Lesiak
Maciej Lesiak
SKSebastian Krych
Sebastian Krych
GWGrzegorz Wallner
Grzegorz Wallner
One of the target of perioperative tratment in surgery is decreasing intraoperative bleeding, which increases the number of perioperative procedures, mortality and treatment costs, and also causes the risk of transfusion of blood and its components. Trying to minimize the blood loss(mainly during the operation) as well as the need to transfuse blood and its components (broadly understood perioperative period) should be standard treatment for a patient undergoing a procedure. In the case of this method, the following steps should be taken: 1) in the preoperative period: identyfication of risk groups as quickly as possible, detecting and treating anemia, applying prehabilitation, modyfying anticoagulant treatment, considering donating one's own blood in some patients and in selected cases erythropoietin preparations; 2) in the perioperative period: aim for normothermia, normovolemia and normoglycemia, use of surgical methods that reduce bleeding, such as minimally invasive surgery, high-energy coagulation, local hemostatics, prevention of surgical site infection, proper transfusion of blood and its components if it occurs; 3) in the postoperative period: monitor the condition of patients, primarily for the detection of bleeding, rapid reoperation if required, suplementation (oral administration preferred) nutrition with microelements (iron) and vitamins, updating its general condition. All these activities, comprehensively and in surgical cooperation with the anesthesiologist, should reduce the blood loss and transfusion of blood and its components.

6 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AJAgata Jęczmyk
Agata Jęczmyk
SKSebastian Krych
Sebastian Krych
MJMałgorzata Jekiełek
Małgorzata Jekiełek
MJMichał Jurkiewicz
Michał Jurkiewicz
PKPaweł Kowalczyk
Paweł Kowalczyk
THTomasz Hrapkowicz
Tomasz Hrapkowicz
Median sternotomy is one of the most common procedures in cardiac surgery. This corresponds to the relatively high frequency of infections where surgical incisions are performed. In the prevention of healing disorders, the medical staff intervention is important, as is the patient. The management of wound infection after sternotomy requires a holistic approach. It requires the implementation of adequate antibiotic therapy, surgical treatment of the wound, and, if necessary, reconstruction of tissue defects using skin, muscle, and skin–muscle grafts or greater omentum. The prevention of surgical site infection should be based on asepsis and antisepsis at every stage of surgical treatment; the elimination of modifiable risk factors; and an appropriate, staged, and tension-free technique of chest closure. The described actions are aimed at avoiding the most serious complication associated with a high mortality rate in the form of mediastinitis. The therapeutic procedures are strictly dependent on the degree of tissue involvement and the presented clinical manifestation. During the preparation of this manuscript, scientific publications available on the Pubmed platform were analyzed. The scope of the search was limited to the years 2014–2024. The key words were “sternotomy wound infection”. A total of 114 publications were analyzed, and 56 of them were included. A total of 23 papers were used to discuss the topic.

26 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MJMichał Jurkiewicz
Michał Jurkiewicz
WSWioletta Szczurek-Wasilewicz
Wioletta Szczurek-Wasilewicz
MSMichał Skrzypek
Michał Skrzypek
SKSebastian Krych
Sebastian Krych
MGMariusz Gąsior
Mariusz Gąsior
BSBożena Szyguła-Jurkiewicz
Bożena Szyguła-Jurkiewicz
Background/Objective: Risk stratification in elderly patients with heart failure (HF) is very difficult. There is a lack of reliable tools for assessing the risk of death in this population of patients. The aim of this study was to determine the association between albumin–bilirubin (ALBI) score and long-term mortality in hospitalized elderly patients with decompensated HF. Methods: The study included 242 consecutive HF patients aged over 65 years hospitalized for worsening chronic HF at our institution between 2019 and 2023. The ALBI score was calculated according to the appropriate formula. Results: The median (IQR) age of the study population was 68.00 (range 66.0 to 74.6) years and 21.1% were female. The mean follow-up time was 352 ± 293 days. During the follow-up period, 47.1% patients died. The ALBI score generated good prognostic power (area under the curve = 0.822, p < 0.01) and specificity (86%) as well as acceptable sensitivity (68%) when predicting long-term mortality. Patients with higher ALBI scores (≥−2.191) had significantly worse long-term survival than patients with lower ALBI scores (<−2.191) [37 (25.2%) vs. 77 (81.1%); log rank p < 0.001]. Conclusions: This is the first study demonstrating that ALBI score has good prognostic power and allows for the successful prediction of mortality during long-term follow-up in the analyzed cohort.

Verified
Journal Article
Open access
PDF file
SKSebastian Krych
Sebastian Krych
JGJulia Gniewek
Julia Gniewek
MKMarek Kolbowicz
Marek Kolbowicz
MAMaria Adamczyk
Maria Adamczyk
THTomasz Hrapkowicz
Tomasz Hrapkowicz
PKPaweł Kowalczyk
Paweł Kowalczyk
Aortic diseases, including thoracic and abdominal aneurysms as well as aortic dissections, represent life-threatening vascular disorders characterized by progressive wall degeneration and inflammation. Increasing evidence indicates that oxidative stress is a central driver of aortic pathology through the induction of DNA damage in vascular smooth muscle cells and endothelial cells. Oxidative DNA lesions activate the DNA damage response (DDR), a highly coordinated network of damage sensors, signaling kinases, and repair effectors that determines cell fate decisions such as DNA repair, apoptosis, or cellular senescence. In aortic tissue, persistent or dysregulated DDR signaling contributes to chronic inflammation, extracellular matrix degradation, and loss of vascular integrity. Key molecular regulators, including base excision repair enzymes OGG1 and APE1, as well as DDR mediators such as ATM, ATR, p53, PARP, and NOTCH1, integrate oxidative stress signals with pro-inflammatory and pro-degenerative pathways. Aberrant activation of these mechanisms promotes vascular smooth muscle cell VSMC phenotypic switching from contractile to synthetic phenotype, endothelial dysfunction, and senescence-associated secretory responses, thereby accelerating aortic wall weakening and aneurysm progression. This review highlights the mechanistic links between oxidative stress-induced DNA damage, DDR pathway activation, and vascular remodeling in aortopathies. A deeper understanding of these molecular interactions may uncover novel biomarkers and therapeutic targets aimed at limiting inflammation, preserving genomic stability, and preventing catastrophic aortic events. This work represents a narrative review and therefore has inherent limitations in terms of systematic literature search and selection.